Expoint โ€“ all jobs in one place
ืžืฆื™ืืช ืžืฉืจืช ื”ื™ื™ื˜ืง ื‘ื—ื‘ืจื•ืช ื”ื˜ื•ื‘ื•ืช ื‘ื™ื•ืชืจ ืžืขื•ืœื ืœื ื”ื™ื™ืชื” ืงืœื” ื™ื•ืชืจ

ื“ืจื•ืฉื™ื Asociado De Farmacovigilancia Ii ื‘-ื˜ื‘ืข ื‘-Mexico, Mexico City

ืžืฆืื• ืืช ื”ื”ืชืืžื” ื”ืžื•ืฉืœืžืช ืขื‘ื•ืจื›ื ืขื ืืงืกืคื•ื™ื ื˜! ื—ืคืฉื• ื”ื–ื“ืžื ื•ื™ื•ืช ืขื‘ื•ื“ื” ื‘ืชื•ืจ Asociado De Farmacovigilancia Ii ื‘-Mexico, Mexico City ื•ื”ืฆื˜ืจืคื• ืœืจืฉืช ื”ื—ื‘ืจื•ืช ื”ืžื•ื‘ื™ืœื•ืช ื‘ืชืขืฉื™ื™ืช ื”ื”ื™ื™ื˜ืง, ื›ืžื• Teva. ื”ื™ืจืฉืžื• ืขื›ืฉื™ื• ื•ืžืฆืื• ืืช ืขื‘ื•ื“ืช ื”ื—ืœื•ืžื•ืช ืฉืœืš ืขื ืืงืกืคื•ื™ื ื˜!
ื—ื‘ืจื” (1)
ืื•ืคื™ ื”ืžืฉืจื”
ืงื˜ื’ื•ืจื™ื•ืช ืชืคืงื™ื“
ืฉื ืชืคืงื™ื“ (1)
Mexico
Mexico City
ื ืžืฆืื• 2 ืžืฉืจื•ืช
26.05.2025
T

Teva Asociado de Farmacovigilancia II Mexico, Mexico City, Mexico City

Limitless High-tech career opportunities - Expoint

ืฉื™ืชื•ืฃ

ื”ืชื—ื‘ืจ/ื™ ื›ื“ื™ ืœื”ื’ื™ืฉ ืžื•ืขืžื“ื•ืช
ืชื™ืื•ืจ:
Ensure the effective operations of the US Generics Commercial and Sales Team. Coordinate corporate business reporting for US Generics, including gathering information and preparing presentations for Quarterly Business Reviews, Investor...
ืคืจื˜ื™ ื”ืžืฉืจื” ื”ืžืœืื™ื

ืžืฉืจื•ืช ื ื•ืกืคื•ืช ืฉื™ื›ื•ืœื•ืช ืœืขื ื™ื™ืŸย ืื•ืชืš

25.05.2025
T

Teva Pharmacovigilance Associate II Mexico, Mexico City, Mexico City

Limitless High-tech career opportunities - Expoint

ืฉื™ืชื•ืฃ

ื”ืชื—ื‘ืจ/ื™ ื›ื“ื™ ืœื”ื’ื™ืฉ ืžื•ืขืžื“ื•ืช
ืชื™ืื•ืจ:
Responsible for the receipt of adverse event information, including XMLs extraction, upload and receipt. Performs case registration of adverse event reports by entering search information. Responsible for submitting adverse event...
ืคืจื˜ื™ ื”ืžืฉืจื” ื”ืžืœืื™ื
ื‘ื•ืื• ืœืžืฆื•ื ืืช ืขื‘ื•ื“ืช ื”ื—ืœื•ืžื•ืช ืฉืœื›ื ื‘ื”ื™ื™ื˜ืง ืขื ืืงืกืคื•ื™ื ื˜. ื‘ืืžืฆืขื•ืช ื”ืคืœื˜ืคื•ืจืžื” ืฉืœื ื• ืชื•ื›ืœ ืœื—ืคืฉ ื‘ืงืœื•ืช ื”ื–ื“ืžื ื•ื™ื•ืช Asociado De Farmacovigilancia Ii ื‘ื—ื‘ืจืช Teva ื‘-Mexico, Mexico City. ื‘ื™ืŸ ืื ืืชื ืžื—ืคืฉื™ื ืืชื’ืจ ื—ื“ืฉ ื•ื‘ื™ืŸ ืื ืืชื ืจื•ืฆื™ื ืœืขื‘ื•ื“ ืขื ืืจื’ื•ืŸ ืกืคืฆื™ืคื™ ื‘ืชืคืงื™ื“ ืžืกื•ื™ื, Expoint ืžืงืœื” ืขืœ ืžืฆื™ืืช ื”ืชืืžืช ื”ืขื‘ื•ื“ื” ื”ืžื•ืฉืœืžืช ืขื‘ื•ืจื›ื. ื”ืชื—ื‘ืจื• ืœื—ื‘ืจื•ืช ืžื•ื‘ื™ืœื•ืช ื‘ืื–ื•ืจ ืฉืœื›ื ืขื•ื“ ื”ื™ื•ื ื•ืงื“ืžื• ืืช ืงืจื™ื™ืจืช ื”ื”ื™ื™ื˜ืง ืฉืœื›ื! ื”ื™ืจืฉืžื• ื”ื™ื•ื ื•ืขืฉื• ืืช ื”ืฆืขื“ ื”ื‘ื ื‘ืžืกืข ื”ืงืจื™ื™ืจื” ืฉืœื›ื ื‘ืขื–ืจืช ืืงืกืคื•ื™ื ื˜.